The Accelerated Approval Program for Oncology Drugs: Celebrating More Than 250,000 Life-Years Gained and Counting Read more about The Accelerated Approval Program for Oncology Drugs: Celebrating More Than 250,000 Life-Years Gained and Counting
Analyzing Accelerated Approval for Oncology Drugs: NPC Commentary Evaluates Evidence on FDA Program Effectiveness, Concludes Benefits Outweigh Risks Read more about Analyzing Accelerated Approval for Oncology Drugs: NPC Commentary Evaluates Evidence on FDA Program Effectiveness, Concludes Benefits Outweigh Risks
NPC Submits Comments on Next Steps in the 21st Century Cures Initiative Read more about NPC Submits Comments on Next Steps in the 21st Century Cures Initiative
NPC Submits Comments to CMS on Draft Guidance for the Medicare Drug Price Negotiation Program for 2027 Read more about NPC Submits Comments to CMS on Draft Guidance for the Medicare Drug Price Negotiation Program for 2027
Unanswered Questions and Unintended Consequences of State Prescription Drug Affordability Boards Read more about Unanswered Questions and Unintended Consequences of State Prescription Drug Affordability Boards
Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program Read more about Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program
NPC Comments Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights Read more about NPC Comments Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights
Unintended Consequences of the Inflation Reduction Act: Clinical Development Toward Subsequent Indications Read more about Unintended Consequences of the Inflation Reduction Act: Clinical Development Toward Subsequent Indications
NPC Comments on HHS Notice of Benefit and Payment Parameters for 2025 Read more about NPC Comments on HHS Notice of Benefit and Payment Parameters for 2025
NPC Submits Comments to CMS on Proposed Changes to Medicare Programs Read more about NPC Submits Comments to CMS on Proposed Changes to Medicare Programs